Schering Says Plans to Defend Yasmin Patent
FRANKFURT (Reuters) - German drug maker Schering plans to defend its patent on popular oral contraceptive Yasmin against a challenge by U.S. rival Barr Pharmaceuticals Inc., the Berlin-based company said on Wednesday.
Continue to Schering Says Plans to Defend Yasmin Patent on Reuters: Health.
Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz
